These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 18304423)

  • 21. [In vitro anti-tumor effect of CTL induced by HSP70-Id complex-modified dendritic cells].
    Wang ZH; Ye Q; Hu ZQ; Ye ZQ; Yu X; Shen GX
    Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):481-5. PubMed ID: 17147108
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation of CMRF-44+ monocyte-derived dendritic cells: insights into phenotype and function.
    Vuckovic S; Fearnley DB; Mannering SI; Dekker J; Whyte LF; Hart DN
    Exp Hematol; 1998 Dec; 26(13):1255-64. PubMed ID: 9845382
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biological characteristics of dendritic cells derived from peripheral blood of patients with epithelial ovarian cancer.
    Lan CY; Liu JH; Xia JC; Zheng LM
    Ai Zheng; 2009 Feb; 28(2):132-7. PubMed ID: 19550123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Rescue of dendritic cells malfunction and loading with HBV proteins in patients with chronic hepatitis B in vitro].
    Duan XZ; Su HB; Chen J; Zhang AM; Hu JH; Wang HF
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Oct; 23(5):328-30. PubMed ID: 20387476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunostimulatory CpG-oligodeoxynucleotides (CpG-ODN) induce early hepatic injury, but provide a late window for protection against endotoxin-mediated liver damage.
    Slotta JE; Scheuer C; Menger MD; Vollmar B
    J Hepatol; 2006 Mar; 44(3):576-85. PubMed ID: 16310279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interferon gamma impairs the ability of monocyte-derived dendritic cells to present tumour-specific and allo-specific antigens and reduces their expression of CD1A, CD80 AND CD4.
    Rongcun Y; Maes H; Corsi M; Dellner F; Wen T; Kiessling R
    Cytokine; 1998 Oct; 10(10):747-55. PubMed ID: 9811527
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis B virus surface antigen can activate human monocyte-derived dendritic cells by nuclear factor kappa B and p38 mitogen-activated protein kinase mediated signaling.
    Jan RH; Lin YL; Chen CJ; Lin TY; Hsu YC; Chen LK; Chiang BL
    Microbiol Immunol; 2012 Oct; 56(10):719-27. PubMed ID: 22853328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD40-dependent and -independent activation of human tonsil B cells by CpG oligodeoxynucleotides.
    Gantner F; Hermann P; Nakashima K; Matsukawa S; Sakai K; Bacon KB
    Eur J Immunol; 2003 Jun; 33(6):1576-85. PubMed ID: 12778475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of CpG motif containing oligodeoxynucleotides on dendritic cell function in patients with chronic hepatitis B.
    You Y; Fan X; Huang Z; Li N
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Jun; 34(6):461-7. PubMed ID: 19587425
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The maturation-dependent production of interleukin-16 is impaired in monocyte-derived dendritic cells from atopic dermatitis patients but is restored by inflammatory cytokines TNF-alpha and IL-1beta.
    Reich K; Hugo S; Middel P; Blaschke V; Heine A; Neumann C
    Exp Dermatol; 2004 Dec; 13(12):740-7. PubMed ID: 15560757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CpG oligodeoxynucleotides induce human monocytes to mature into functional dendritic cells.
    Gursel M; Verthelyi D; Klinman DM
    Eur J Immunol; 2002 Sep; 32(9):2617-22. PubMed ID: 12207346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CpG ODN enhance antigen-specific NKT cell activation via plasmacytoid dendritic cells.
    Marschner A; Rothenfusser S; Hornung V; Prell D; Krug A; Kerkmann M; Wellisch D; Poeck H; Greinacher A; Giese T; Endres S; Hartmann G
    Eur J Immunol; 2005 Aug; 35(8):2347-57. PubMed ID: 16025562
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Changes in the immune function of dendritic cells (DC) derived from HBV-related hepatocellular carcinoma (HCC) patient's peripheral blood monocytes (PBMC) pulsed with tumor antigen].
    Wong YQ; Qiu SJ; Tang ZY; Ye SL; Liu YK; Fan J; Sun RX; Zhao Y
    Zhonghua Gan Zang Bing Za Zhi; 2005 May; 13(5):339-42. PubMed ID: 15918966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [CpG oligodeoxynucleotide enhances humoral and cellular immune responses against HBsAg in mice].
    Zhou Z; Chen WS; Yao JL
    Zhonghua Nei Ke Za Zhi; 2003 Sep; 42(9):640-2. PubMed ID: 14514394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CpG oligodeoxynucleotide-adjuvanted fusion peptide derived from HBcAg epitope and HIV-Tat may elicit favorable immune response in PBMCs from patients with chronic HBV infection in the immunotolerant phase.
    Wang S; Han Q; Zhang G; Zhang N; Li Z; Chen J; Lv Y; Li N; Xing F; Tian N; Zhu Q; Liu Z
    Int Immunopharmacol; 2011 Apr; 11(4):406-11. PubMed ID: 21182997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CpG-C immunostimulatory oligodeoxyribonucleotide activation of plasmacytoid dendritic cells in rhesus macaques to augment the activation of IFN-gamma-secreting simian immunodeficiency virus-specific T cells.
    Teleshova N; Kenney J; Jones J; Marshall J; Van Nest G; Dufour J; Bohm R; Lifson JD; Gettie A; Pope M
    J Immunol; 2004 Aug; 173(3):1647-57. PubMed ID: 15265893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of adenoviral gene transfer of mutated IkappaBalpha, a novel inhibitor of NF-kappaB, on human monocyte-derived dendritic cells.
    Zhou LF; Zhang MS; Yin KS; Ji Y; Xie WP; Cui XF; Ji XH
    Acta Pharmacol Sin; 2006 May; 27(5):609-16. PubMed ID: 16626517
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CpG oligodeoxynucleotide prolongs eosinophil survival through activation of contaminating B cells and plasmacytoid dendritic cells in vitro.
    Matsumoto K; Terakawa M; Fukuda S; Kato A; Toki S; Shinohara M; Wakiguchi H; Saito H
    Int Arch Allergy Immunol; 2006; 140 Suppl 1():42-50. PubMed ID: 16772726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanoparticles encapsulating hepatitis B virus cytosine-phosphate-guanosine induce therapeutic immunity against HBV infection.
    Lv S; Wang J; Dou S; Yang X; Ni X; Sun R; Tian Z; Wei H
    Hepatology; 2014 Feb; 59(2):385-94. PubMed ID: 23907803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunomodulatory effect of cytosine-phosphate-guanosine (CpG)-oligonucleotides in nonasthmatic chronic rhinosinusitis: an explant model.
    Tan L; Rogers TJ; Hatzirodos N; Baker LM; Ooi E; Wormald PJ
    Am J Rhinol Allergy; 2009; 23(2):123-9. PubMed ID: 19401034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.